2)La Thangue NB, Kerr DJ. Predictive biomarkers:a paradigm shift towards personalized cancer medi-cine. Nat Rev Clin Oncol 2011;8:587.
3)Pao W, Girard N. New drlver mutations in non-small.cell lung cancer. Lancet Oncol 2011;12:175.
4)Sequist LV, Waltman BA, Dias-Santagata D, et al. Genotypic and histological evolution of lung can-cers acquiring resistance to EGFR inhibitors. Sci Transl Med 2011;3:75ra26.